Navigation Links
Reportlinker Adds Global Immunoassay Systems Industry
Date:9/30/2010

NEW YORK, Sept. 30 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Immunoassay Systems Industry

http://www.reportlinker.com/p0305127/Global-Immunoassay-Systems-Industry.html

This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following product segments - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 69 companies including many key and niche players such as Abbott Laboratories, Beckman Coulter Inc., bioMerieux, Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

IMMUNOASSAY SYSTEMS MCP-3522

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Enzyme Immunoassay I-4

Fluorescence Immunoassay I-4

Chemiluminescence Immunoassay I-4

Radioimmunoassay I-5

Nephelometric Immunoassay I-5

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

In-Vitro Diagnostics - A Rudimentary Overview II-1

Technologies Used in IVD II-1

Market Structure II-2

Factors Influencing IVD Industry: On a Scale of 1-5 II-3

Key Statistical Findings: II-3

Table 1: World In-Vitro Diagnostic Products Market by

End-Use Segment (2009) - Percentage Breakdown by Value

Sales for Hospital Labs, Commercial Labs, Self-Testing and

POC (includes corresponding Graph/Chart) II-3

Table 2: Global IVD Market (2008): Percentage Share

Breakdown of Value Sales by Country/Region (includes

corresponding Graph/Chart) II-3

Table 3: Global IVD Market (2008): Percentage Share

Breakdown of Revenue by Product Segment (includes

corresponding Graph/Chart) II-4

Competition in the IVD Market II-4

Table 4: Global IVD Market (2009): Percentage Share

Breakdown of Value Sales by Leading Players (includes

corresponding Graph/Chart) II-4

Immunoassays - A Key Component in the IVD Market II-5

Waxing Importance of Immunoassays in the Overall Diagnostic

Test Market II-5

Expanding Immunoassay Applications Boost Demand for

Immunoassay Systems II-6

Table 5: Global Laboratory Based Immunoassay Market (2009):

Percentage Share Breakdown of Value Sales by Analyte Type

(includes corresponding Graph/Chart) II-7

Table 6: Recent Past Perspective of the World Immunoassay

Market by End-Use Industry (2006): Percentage Breakdown by

Value Sales for Clinical, Food and Environment Industries

(includes corresponding Graph/Chart) II-7

Increasing Use of Immunoassays in Food Sciences and Quality

Control II-7

Immunoassay Techniques for Testing Environmental Samples

Makes a Mark II-8

Application of Immunoassays for Trace Methodology II-8

Technology Innovation - The Name of the Game II-8

Table 7: Worldwide Immunoassay Systems Market (2007) -

Percentage Share Breakdown of Value Sales by Leading Players

(includes corresponding Graph/Chart) II-9

2. INDUSTRY TRENDS & ISSUES II-10

Shift Towards Point-of-Care Test Systems II-10

Hospital and Laboratory Consolidations Drive the Market for

Immunoassay Products II-10

Advancement in Genetic Research Drives the Growth II-10

Introduction of Portable Immunoassay Systems Energizes the

Market II-11

Increasing Demand for Random Access Immunoanalyzers..... II-11

Task-Targeted Automated Chemiluminescent Assays to Penetrate II-11

Instrument Rental - Name of the New Game... II-11

Changing Scene for Immunodiagnostic Testing... II-11

Laboratory Automation on Rise II-12

Market for Adjunctive Therapies to Grow Fast II-12

3. CONCEPTUAL OVERVIEW II-13

Immunoassays - Definition and Description.... II-13

Turning the Hour Glass Back II-13

Immunoassay Analyzers II-13

Immunoassay Reagents II-14

Radioimmunoassay II-14

Non-Isotopic Immunoassays II-14

Customized Immunoassays II-15

Demerits of Immunoassays II-15

Labels - Necessary for Detection II-15

Select End-Use Applications of Immunoassays II-16

Infectious Disease II-16

Endocrine Testing Procedures II-16

Blood Processing Market II-16

Cancer Testing Markets II-17

Drugs of Abuse Testing Market II-17

Therapeutic Drug Monitoring II-18

Immune Disease II-18

Blood Grouping and Typing II-18

Components of Immunoassays II-18

Signal Response II-19

Labeled Tracer II-19

Binder II-19

Buffer Matrix II-19

Incubation Conditions II-19

Separation Process II-19

Standard Specimens II-20

Control Specimens II-20

Unknown Specimens II-20

Chemiluminescent Substrates - Growing Appeal II-20

Radioimmunoassay Analyzers, Gamma Counters II-20

Fundamentals of Operation II-21

Problems Involved II-22

Enzyme Immunoassay Analyzers, Fluorescence Immunoassay

Analyzers and Chemiluminescence's Immunoassay Analyzers II-23

Enzyme Immunoassays II-24

Automation Enabled II-24

Customization of Assays II-24

ELISA - A Flexible Enzyme Immunoassay Test..... II-25

Constituents of ELISA II-25

Working II-25

Binding the Antigen and Antibody II-25

Conjugate Binding II-26

Evidence of Binding II-26

Fluorescence Immunoassay - Operating Principle II-26

Light Sources II-26

Sample Cell II-26

Filters II-27

Detector II-27

Time-Resolved Fluoroimmunoassay II-27

Chemiluminescence Immunoassay II-27

Types of Immunoassay Techniques II-28

Fluorescence Polarization Immunoassay II-28

Radiative Energy Attenuation (REA) II-28

Substrate-Labeled Fluorescence II-29

Enzyme Immunoassay with Fluorescence Detection II-29

Solid-Phase Microsphere Immunoassay II-29

Microparticle Enzyme Immunoassay (MEIA) II-30

Enzyme-Linked Fluorescence Immunoassay II-30

ELISA With Photometric Detection II-30

Dry-Phase Techniques II-31

Sandwich Technique II-31

Competitive Binding II-31

Reversible Complex Formation II-31

The Phase of Development II-31

Problems and Limitations.... II-32

Purchase Considerations..... II-33

Cost Considerations.... II-33

Nephelometric Immunoassay II-33

Nephelometry II-34

Types of Scatter...... II-34

Rayleigh Scatter II-34

Mie Scatter II-34

Rayleigh-Debye Scatter II-34

Key Components of Nephelometric Immunoassay Analyzers.... II-34

Light Sources II-35

Detectors II-35

Automated Nephelometers.... II-35

Modes of Operation.... II-36

Nephelometric Immunoassay Procedures.... II-36

Associated Problems...... II-37

Purchase Considerations.... II-37

Test Menu II-38

Analytical Range II-38

Linearity II-38

Specificity II-38

Precision II-38

Stability II-38

Carryover II-38

Downtime II-39

Upgrading / Interfacing II-39

Reagents II-39

Additional Features..... II-39

Competing Technologies II-39

Mature Technologies..... II-39

Cell Counting II-39

Clinical Chemistry II-40

Microbiology II-40

Emerging Technologies...... II-40

DNA Probes II-40

Miniaturization and Microchip Fabrication II-40

Blood Glucose Testing II-41

Immunohistochemistry (IHC) II-41

Non-Invasive Technology II-41

Image Analysis and Pattern Recognition II-41

Rapidly Growing Molecular Diagnostics II-42

New Technologies II-42

High-Definition Cell Assay Technologies: II-42

(1) Rapid, High-Definition Assays for Cellular Efficacy

(RHACE) II-42

(2) Single-Cell Analysis of Physiological Effects (SAPhE) II-42

(3) Matrix Analysis of Genomically-Indexed Cells (MAGIC) II-42

4. PRODUCT LAUNCHES II-43

Roche Introduces Roche Cardiac 200 II-43

Bio-Rad Introduces Bio-Plex Pro™ II-43

IDS Introduces IDS-iSYS hGH II-43

IDS Introduces IDS-iSYS PINP II-43

IDS Introduces IDS-iSYS & IDS-iSYS Vitamin D Assay II-43

Abbott Introduces ARCHITECT c4000 Clinical Chemistry Analyzer II-44

Siemens Introduces Clinical Laboratory Automation Solutions II-44

Ortho-Clinical Diagnostics Introduces New Laboratory System II-45

Cell Biosciences Launches Kit for Analysis of Oncoproteins II-46

Roche Diagnostics Introduces Pre-Eclampsia In-Vitro Tests

across Europe II-46

Abbott To Launch New ARCHITECT® ci4100™ Integrated

Immunoassay & Clinical Chemistry System II-46

Abbott Introduces ARCHITECT® i1000SR® Immunochemistry Analyzer II-47

Ortho Clinical Diagnostics Unveils Vitros® 3600

Immunodiagnostic System and Vitros® 5600 Integrated System II-47

PerkinElmer Releases New AplhaLISA™ Immunoassay Diagnostic Kits II-48

Assay Designs Introduces ImmunoSet™ ELISA Development Kit II-49

Trinity Biotech Introduces New Lyme Enzyme Diagnostic

Products for European Markets (Europe) II-49

bioMerieux Introduces VIDAS® NT-proBNP II-49

Beckman Coulter Introduces UniCel DxC 880i Synchron® Access® II-50

Beckman Coulter Introduces UniCel® DxI 600 II-50

bioMerieux Introduces VIDAS® B·R·A·H·M·S PCT® Assay II-50

Siemens Rolls Out ADVIA Centaur® Cyclosporine (CsA) Assay II-50

Ortho-Clinical Diagnostics Launches VITROS Troponin I ES Assay II-50

Ortho-Clinical Diagnostics Introduces VITROS® Rubella IgG Assay II-51

5. RECENT INDUSTRY ACTIVITY II-52

bioMerieux Acquires Meikang Biotech II-52

Bio-Rad Purchases Biotest AG's Diagnostics Businesses II-52

Immunodiagnostic Systems Receives FDA Approval for IDS-iSYS

Immunoassay Analyzer II-52

Roche Diagnostics Receives Immunoassay Contract from Premier

Purchasing Partner II-52

Ortho Clinical Gets US FDA Approval for Usage of VITROS®

Hepatitis B Surface Antigen (HBsAG) on VITROS® 5600

Integrated & VITROS® 3600 II-53

Neogen Takes Over International Diagnostic Systems II-53

eBioscience Acquires Bender MedSystems II-53

Inverness to Acquire ACON's Lateral Flow Immunoassay

Diagnostics Business II-54

Beckman Coulter to Purchase Olympus Corp's Diagnostics Division II-54

Instrumentation Laboratory Secures FDA Approval for ACL

AcuStarTM Hemostasis Testing System II-54

Abbott Receives FDA Premarket Approval for ARCHITECT CORE II-55

Ivax Diagnostics Inks Distribution Deal with Lin-Zhi

International II-55

Axis-Shield Inks Distribution Deals for Marketing Afinion II-55

bioMerieux and Shanghai Kehua Set Up JV II-55

bioMerieux and Quidel to Form Global Alliance for Rapid

Diagnostics II-56

Johnson & Johnson Nordic AB Takes Over Amic II-56

Roche Acquires Ventana Medical Systems, Inc. II-57

Abbott Terminates Sale Agreement with GE II-57

Abbott Inks Agreement with Premier, Inc. II-57

Beckman Coulter Renews Agreement with MedAssets II-57

Beckman Coulter Extends Agreement Amerinet II-57

Beckman Coulter Extends Partnership with Bio-Rad II-58

Siemens Acquires Dade Behring II-58

Roche Acquires BioVeris II-58

Siemens Healthcare Diagnostics Inks Agreement with Amerinet II-58

Siemens Healthcare Diagnostics Signs Agreement with Bio-Rad II-58

Siemens Medical Solutions USA Sets Up Siemens Healthcare

Diagnostics II-59

6. FOCUS ON SELECT MARKET PARTICIPANTS II-60

Abbott Laboratories (US) II-60

Beckman Coulter Inc. (US) II-60

bioMerieux (France) II-61

Bio-Rad Laboratories Inc. (US) II-61

Ortho-Clinical Diagnostics Inc (US) II-62

Roche Diagnostics (US) II-62

Siemens Healthcare Diagnostics (US) II-63

7. GLOBAL MARKET PERSPECTIVE II-64

Table 8: World Recent Past, Current & Future Analysis for

Immunoassay Systems by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific and Latin American Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) II-64

Table 9: World Historic Review for Immunoassay Systems by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

and Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) II-65

Table 10: World 11-Year Perspective for Immunoassay Systems

by Geographic Region - Percentage Breakdown of Value Sales

for US, Canada, Japan, Europe, Asia-Pacific and Latin

American Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) II-66

Immunoassay Systems Market by Product Segment II-67

Table 11: World Recent Past, Current & Future Analysis for

Enzyme Immunoassay Systems by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) II-67

Table 12: World Historic Review for Enzyme Immunoassay Systems

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

and Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) II-68

Table 13: World 11-Year Perspective for Enzyme Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin

American Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) II-69

Table 14: World Recent Past, Current & Future Analysis for

Fluorescence Immunoassay Systems by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) II-70

Table 15: World Historic Review for Fluorescence Immunoassay

Systems by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific and Latin American Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) II-71

Table 16: World 11-Year Perspective for Fluorescence

Immunoassay Systems by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific and Latin American Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) II-72

Table 17: World Recent Past, Current & Future Analysis for

Chemiluminescence Immunoassay Systems by Geographic Region -

US, Canada, Japan, Europe,Asia-Pacific and Latin American

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) II-73

Table 18: World Historic Review for Chemiluminescence

Immunoassay Systems by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific and Latin American Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) II-74

Table 19: World 11-Year Perspective for Chemiluminescence

Immunoassay Systems by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific and Latin American Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) II-75

Table 20: World Recent Past, Current & Future Analysis for

Radio Immunoassay Systems & Reagents by Geographic Region -

US, Canada, Japan, Europe, Asia-Pacific and Latin American

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) II-76

Table 21: World Historic Review for Radio Immunoassay Systems

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

and Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) II-77

Table 22: World 11-Year Perspective for Radio Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin

American Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) II-78

Table 23: World Recent Past, Current & Future Analysis for

Nephelometric Immunoassay Systems by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) II-79

Table 24: World Historic Review for Nephelometric Immunoassay

Systems by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific and Latin American Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2001

through 2006 (includes corresponding Graph/Chart) II-80

Table 25: World 11-Year Perspective for Nephelometric

Immunoassay Systems by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific and Latin American Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) II-81

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Market Overview III-1

Trends in the Marketplace III-1

Leading Players III-1

US In-Vitro Diagnostics Market - A Special Review III-1

Evolving Trends to Benefit IVD Market III-2

Key Statistics III-3

Table 26: US In-Vitro Diagnostics (IVD) Market (2008):

Percentage Share Breakdown of Dollar Sales by Segment

(includes corresponding Graph/Chart) III-3

Table 27: US In-Vitro Diagnostics (IVD) Market (2009):

Percentage Share Breakdown of Revenue by Leading Players

(includes corresponding Graph/Chart) III-3

US Market for Clinical Laboratory Instruments III-3

Laboratory Consolidation and Automation on a Rise III-3

Product Launches III-4

Strategic Corporate Developments III-10

Focus on Select Players III-15

Abbott Laboratories III-15

Beckman Coulter III-15

Bio-Rad Laboratories Inc. III-16

Ortho-Clinical Diagnostics Inc III-16

Roche Diagnostics III-17

Siemens Healthcare Diagnostics III-17

B.Market Analytics III-18

Table 28: US Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-18

Table 29: US Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) III-19

Table 30: US 11-Year Perspective for Immunoassay Systems by

Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2005, 2010 & 2015 (includes corresponding

Graph/Chart) III-20

2. CANADA III-21

Market Analysis III-21

Table 31: Canadian Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-21

Table 32: Canadian Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) III-22

Table 33: Canadian 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-23

3. JAPAN III-24

A.Market Analysis III-24

Market Highlights... III-24

Strategic Corporate Development III-24

Focus on Key Players III-24

Fujirebio Inc III-24

Tosoh Corporation III-25

B.Market Analytics III-25

Table 34: Japanese Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-25

Table 35: Japanese Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) III-26

Table 36: Japanese 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-27

4. EUROPE III-28

A. Market Analytics III-28

Current & Future Analysis III-28

Overview of Immunochemistry Analyzer Market in Europe III-28

High Switching Costs and Restricted Hospital Budgets

Inhibit Market Expansion III-28

Panorama of the European Immunoassay Market III-29

Challenges III-29

Decreasing Profitability III-29

Immunodiagnostic Products Market - A Focus III-30

Trends in Immunodiagnostic Market..... III-30

IVD Market - Recent Past Perspective III-31

Table 37: European IVD Market, 2006: Leading Players by

Market Share for Roche, Dade, Abbott, Beckman, Bayer,

bioMerieux, OCD and Others (includes corresponding

Graph/Chart) III-31

Product Launches III-31

Strategic Corporate Development III-32

B.Market Analytics III-33

Table 38: European Recent Past, Current & Future Analysis

for Immunoassay Systems by Geographic Region - France,

Germany, Italy, the UK and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-33

Table 39: European Historic Review for Immunoassay Systems

by Geographic Region - France, Germany, Italy, the UK and

Rest of Europe Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) III-34

Table 40: European Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-35

Table 41: European Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) III-36

Table 42: European 11-Year Perspective for Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for France, Germany, Italy, the UK and Rest of Europe

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) III-37

Table 43: European 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-38

4a. FRANCE III-39

A.Market Analysis III-39

Current & Future Analysis III-39

Strategic Corporate Development III-39

bioMerieux - A Key Player III-39

B.Market Analytics III-40

Table 44: French Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-40

Table 45: French Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) III-41

Table 46: French 11-Year Perspective for Immunoassay Systems

by Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2005, 2010 & 2015 (includes corresponding

Graph/Chart) III-42

4b. GERMANY III-43

A.Market Analysis III-43

Current & Future Analysis III-43

In-Vitro Diagnostics Market - A Snapshot III-43

B.Market Analytics III-44

Table 47: German Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-44

Table 48: German Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) III-45

Table 49: German 11-Year Perspective for Immunoassay Systems

by Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2005, 2010 & 2015 (includes corresponding

Graph/Chart) III-46

4c. ITALY III-47

Market Analysis III-47

Table 50: Italian Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-47

Table 51: Italian Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) III-48

Table 52: Italian 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-49

4d. THE UNITED KINGDOM III-50

A.Market Analysis III-50

Current & Future Analysis III-50

IDS - A Key Player in the UK III-50

Product Launches III-50

B.Market Analytics III-51

Table 53: UK Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-51

Table 54: UK Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) III-52

Table 55: UK 11-Year Perspective for Immunoassay Systems by

Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2005, 2010 & 2015 (includes corresponding

Graph/Chart) III-53

4e. REST OF EUROPE III-54

A.Market Analysis III-54

Current and Future Analysis III-54

Strategic Corporate Development III-54

B.Market Analytics III-55

Table 56: Rest of Europe Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-55

Table 57: Rest of Europe Historic Review for Immunoassay

Systems by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) III-56

Table 58: Rest of Europe 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-57

5. ASIA-PACIFIC III-58

A.Market Analysis III-58

Market Highlights..... III-58

Growing In-Vitro Diagnostics (IVD) Market Fuels the Demand

for Immunoassay Instruments in Asia III-58

Review of Select Asian Markets III-58

China III-58

Chinese Market for Diagnostic Products.... III-58

Influencing Forces III-59

Market Characteristics III-59

Competitive Analysis III-59

Strategies III-60

End-User Analysis III-60

Hospitals III-60

Laboratories III-60

General Population III-61

Difficulties Posed by the Market III-61

Distribution Channels III-61

India III-61

Emerging Trends in the Indian Immunodiagnostics Market III-61

Key Statistics III-62

Table 59: Indian Immunochemistry Instruments & Reagents

Market (2009): Percentage Share Breakdown of Revenue by

Segment III-62

Table 60: Indian Immunochemistry Instruments & Reagents

Market (2009): Percentage Share Breakdown of Revenue by

Product Segment (includes corresponding Graph/Chart) III-62

Table 61: Indian Immunoassay Reagent Market (2009):

Percentage Share Breakdown of Revenue by Reagent Type

(includes corresponding Graph/Chart) III-63

Malaysia III-63

Health Care Services.... III-63

Singapore III-64

Clinical Laboratory Equipment Market in Singapore.... III-64

Market Characteristics III-64

Imports Scene III-64

Distribution III-65

End-User Analysis III-65

Strategic Corporate Developments III-65

B.Market Analytics III-66

Table 62: Asia Pacific Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-66

Table 63: Asia Pacific Historic Review for Immunoassay

Systems by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) III-67

Table 64: Asia Pacific 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-68

6. LATIN AMERICA III-69

Market Analysis III-69

Table 65: Latin American Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) III-69

Table 66: Latin America Historic Review for Immunoassay

Systems by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) III-70

Table 67: Latin American 11-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) III-71

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 69 (including Divisions/Subsidiaries - 108)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 48

Canada 8

Japan 11

Europe 33

France 4

Germany 9

The United Kingdom 3

Italy 4

Rest of Europe 13

Asia-Pacific (Excluding Japan) 7

Middle East 1

------------------------------------------

To order this report:Medical Equipment and Supply Industry: Global Immunoassay Systems Industry

Medical Equipment and Supply Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Global Medical Plastics Industry
2. Reportlinker Adds Global Optoelectronics Industry
3. Reportlinker Adds Global Gas Chromatography Systems Industry
4. Reportlinker Adds Global Protein Drugs Industry
5. Reportlinker Adds Drug Patent Inventor Report 2010
6. Reportlinker Adds Global Drugstores Industry
7. Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015".
8. Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015
9. Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
10. Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014)
11. Reportlinker Adds Top 10 Drug Delivery Technologies (2010 - 2015)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016  Eli Lilly and Company (NYSE: LLY ) ... (pemetrexed disodium) vitamin regimen patent would not presently be infringed ... France , Italy and ... only with dextrose solution.  --> ... of Appeal held that Lilly,s patent would be indirectly infringed ...
(Date:2/12/2016)... Ungarn, February 12, 2016 ... sich auf den ungedeckten medizinischen Bedarf bei ... Ergebnisse seines klinischen Forschungsprogramms bekannt. Das Programm, ... ergab Verbesserungen ihrer respiratorischen Funktionen und anderer ... , ein Medizintechnikunternehmen, das sich auf den ...
(Date:2/11/2016)... -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for ... Company also filed its Quarterly Report on Form 10-Q for ... and Exchange Commission today. --> ... --> --> Net sales for the three ... to $5.4 million from $2.8 million for the three months ...
Breaking Medicine Technology:
(Date:2/12/2016)... Sugar Land, TX (PRWEB) , ... February 12, ... ... the families of southwest Houston and surrounding communities by continuing it’s commitment to ... Fort Bend Family Promise. The organization works closely with area homeless families to ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic ... for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ... in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and ...
(Date:2/12/2016)... , ... February 12, 2016 , ... A lot has ... 35 years. A president has access to health and wellness resources most Americans could ... world, no single individual has a schedule as frenetic as the U.S. President. ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... the field of long term care. With that, says Patrick Loughney, president of ... in administrative roles in long term care environments. His company, which offers prep ...
(Date:2/12/2016)... ... ... Planet Future is a Final Cut Pro X themed package ... pictures, videos as well as text in an exciting cartoon environment. Planet Future is ... beautiful frame overlay. Pixel Film Studios makes editing easy; simply insert media into the ...
Breaking Medicine News(10 mins):